A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
|Articles|October 28, 2021
- October 2021
- Volume 87
- Issue 10
Pet Peeves: October 2021
Advertisement
Impatient Patient
People who come early before their appointment for covid test and get mad they have to wait.
A Tight Squeeze
People who ask for items that don’t fit through the drive-through.
A Family Affair
When customers ask you to look up another family member after you just rang them out.
What’s Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We’ll share them here and online.
Articles in this issue
about 5 years ago
OTC Case Studies: Inflammatory Bowel Diseaseabout 5 years ago
Generics and Biosimilars Have Critical Differencesabout 5 years ago
Case Studies: October 2021about 5 years ago
Clinical Pharmacology Update: Brexafemme From Scynexis, Incabout 5 years ago
October 2021 OTC Product Newsabout 5 years ago
CGM Improves Outcomes for Patients Using Only Basal Insulinabout 5 years ago
Pharmacies Play Key Role as Center of Immunization ServicesAdvertisement
Related to this article
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
2
Diabetes Awareness Month Opens Amid New T1D, T2D Approvals
3
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5